Amylyx Pharmaceuticals IncNASDAQ:AMLX
- LAST PRICE3.0600
- TODAY'S CHANGE (%)-0.1800 (-5.5556%)
- Bid / Lots3.0600/ 1
- Ask / Lots3.1500/ 1
- Open / Previous Close3.2500 / 3.2400
- Day Range
- 52 Week Range
- Volume1,134,452
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMLX |
|---|---|---|
| 09:32 ET | 9499 | 3.2845 |
| 09:34 ET | 7971 | 3.285 |
| 09:36 ET | 30650 | 3.2 |
| 09:38 ET | 5480 | 3.18 |
| 09:39 ET | 3361 | 3.1899 |
| 09:41 ET | 8605 | 3.1991 |
| 09:43 ET | 16233 | 3.205 |
| 09:45 ET | 300 | 3.21 |
| 09:48 ET | 1216 | 3.19 |
| 09:50 ET | 6510 | 3.2 |
| 09:52 ET | 250 | 3.205 |
| 09:54 ET | 3979 | 3.185 |
| 09:56 ET | 21854 | 3.165 |
| 09:57 ET | 7935 | 3.17 |
| 09:59 ET | 3394 | 3.17 |
| 10:01 ET | 6220 | 3.17 |
| 10:03 ET | 2786 | 3.15 |
| 10:06 ET | 4684 | 3.1399 |
| 10:08 ET | 13805 | 3.15 |
| 10:10 ET | 3847 | 3.15 |
| 10:12 ET | 4120 | 3.125 |
| 10:14 ET | 79545 | 3.085 |
| 10:15 ET | 6770 | 3.0988 |
| 10:17 ET | 4805 | 3.09 |
| 10:19 ET | 4526 | 3.085 |
| 10:21 ET | 5426 | 3.075 |
| 10:24 ET | 2600 | 3.085 |
| 10:26 ET | 16045 | 3.1299 |
| 10:28 ET | 7919 | 3.11 |
| 10:30 ET | 10482 | 3.105 |
| 10:32 ET | 13095 | 3.1193 |
| 10:33 ET | 2417 | 3.12 |
| 10:35 ET | 1300 | 3.125 |
| 10:37 ET | 1248 | 3.125 |
| 10:39 ET | 1350 | 3.115 |
| 10:42 ET | 790 | 3.115 |
| 10:44 ET | 1200 | 3.12 |
| 10:46 ET | 900 | 3.11 |
| 10:48 ET | 2768 | 3.115 |
| 10:50 ET | 1909 | 3.115 |
| 10:51 ET | 410 | 3.115 |
| 10:53 ET | 5864 | 3.125 |
| 10:55 ET | 1700 | 3.11 |
| 10:57 ET | 4327 | 3.115 |
| 11:00 ET | 4850 | 3.125 |
| 11:02 ET | 1600 | 3.125 |
| 11:04 ET | 15704 | 3.11 |
| 11:06 ET | 300 | 3.1101 |
| 11:08 ET | 4775 | 3.1 |
| 11:09 ET | 6936 | 3.095 |
| 11:11 ET | 3100 | 3.085 |
| 11:13 ET | 12748 | 3.075 |
| 11:15 ET | 10044 | 3.07 |
| 11:18 ET | 2075 | 3.0697 |
| 11:20 ET | 9607 | 3.075 |
| 11:22 ET | 4878 | 3.0714 |
| 11:24 ET | 2581 | 3.075 |
| 11:26 ET | 2158 | 3.07 |
| 11:27 ET | 7898 | 3.08 |
| 11:29 ET | 3457 | 3.07 |
| 11:31 ET | 1258 | 3.075 |
| 11:33 ET | 3047 | 3.08 |
| 11:36 ET | 17683 | 3.09 |
| 11:40 ET | 3708 | 3.085 |
| 11:42 ET | 2000 | 3.085 |
| 11:44 ET | 4912 | 3.09 |
| 11:45 ET | 464 | 3.09 |
| 11:47 ET | 500 | 3.0892 |
| 11:49 ET | 150 | 3.0888 |
| 11:51 ET | 1157 | 3.08 |
| 11:54 ET | 2786 | 3.075 |
| 11:56 ET | 400 | 3.07 |
| 11:58 ET | 510 | 3.075 |
| 12:00 ET | 1075 | 3.075 |
| 12:02 ET | 816 | 3.0789 |
| 12:03 ET | 2325 | 3.075 |
| 12:05 ET | 5112 | 3.08 |
| 12:07 ET | 3714 | 3.089 |
| 12:09 ET | 4808 | 3.0989 |
| 12:12 ET | 744 | 3.095 |
| 12:16 ET | 4300 | 3.09 |
| 12:18 ET | 1284 | 3.085 |
| 12:20 ET | 2633 | 3.0844 |
| 12:21 ET | 3263 | 3.075 |
| 12:23 ET | 564 | 3.08 |
| 12:25 ET | 200 | 3.075 |
| 12:27 ET | 954 | 3.075 |
| 12:30 ET | 4229 | 3.0788 |
| 12:32 ET | 9818 | 3.09 |
| 12:34 ET | 2058 | 3.08 |
| 12:36 ET | 7529 | 3.07 |
| 12:38 ET | 269 | 3.0711 |
| 12:39 ET | 17358 | 3.085 |
| 12:41 ET | 598 | 3.08 |
| 12:43 ET | 4233 | 3.07 |
| 12:45 ET | 805 | 3.07 |
| 12:48 ET | 4821 | 3.075 |
| 12:50 ET | 660 | 3.0785 |
| 12:52 ET | 700 | 3.0788 |
| 12:54 ET | 938 | 3.075 |
| 12:56 ET | 8879 | 3.09 |
| 12:57 ET | 500 | 3.085 |
| 12:59 ET | 25280 | 3.1111 |
| 01:01 ET | 1960 | 3.115 |
| 01:03 ET | 3252 | 3.1003 |
| 01:06 ET | 3461 | 3.1 |
| 01:08 ET | 577 | 3.095 |
| 01:10 ET | 1748 | 3.08 |
| 01:12 ET | 548 | 3.085 |
| 01:14 ET | 2395 | 3.085 |
| 01:15 ET | 8965 | 3.085 |
| 01:17 ET | 495 | 3.08 |
| 01:19 ET | 374 | 3.085 |
| 01:21 ET | 909 | 3.08 |
| 01:24 ET | 948 | 3.085 |
| 01:26 ET | 2824 | 3.08 |
| 01:28 ET | 680 | 3.075 |
| 01:30 ET | 500 | 3.075 |
| 01:32 ET | 4162 | 3.085 |
| 01:33 ET | 2343 | 3.08 |
| 01:35 ET | 400 | 3.085 |
| 01:37 ET | 4068 | 3.095 |
| 01:39 ET | 2307 | 3.095 |
| 01:42 ET | 318 | 3.095 |
| 01:44 ET | 11235 | 3.085 |
| 01:46 ET | 6083 | 3.085 |
| 01:48 ET | 1691 | 3.095 |
| 01:50 ET | 3376 | 3.09 |
| 01:51 ET | 4659 | 3.095 |
| 01:53 ET | 8740 | 3.12 |
| 01:55 ET | 2886 | 3.12 |
| 01:57 ET | 405 | 3.12 |
| 02:00 ET | 1101 | 3.12 |
| 02:02 ET | 1962 | 3.12 |
| 02:04 ET | 1600 | 3.115 |
| 02:06 ET | 948 | 3.12 |
| 02:08 ET | 1898 | 3.12 |
| 02:09 ET | 585 | 3.125 |
| 02:11 ET | 641 | 3.13 |
| 02:13 ET | 200 | 3.125 |
| 02:15 ET | 4075 | 3.135 |
| 02:18 ET | 4850 | 3.135 |
| 02:20 ET | 1300 | 3.125 |
| 02:22 ET | 800 | 3.1297 |
| 02:24 ET | 1314 | 3.13 |
| 02:26 ET | 392 | 3.135 |
| 02:27 ET | 100 | 3.135 |
| 02:29 ET | 586 | 3.135 |
| 02:31 ET | 1436 | 3.14 |
| 02:33 ET | 2968 | 3.14 |
| 02:36 ET | 464 | 3.135 |
| 02:38 ET | 200 | 3.135 |
| 02:40 ET | 1884 | 3.13 |
| 02:42 ET | 988 | 3.13 |
| 02:44 ET | 10196 | 3.115 |
| 02:45 ET | 2557 | 3.12 |
| 02:47 ET | 7204 | 3.13 |
| 02:49 ET | 4770 | 3.135 |
| 02:51 ET | 2215 | 3.135 |
| 02:54 ET | 2214 | 3.13 |
| 02:56 ET | 2443 | 3.1 |
| 02:58 ET | 3714 | 3.115 |
| 03:00 ET | 2703 | 3.12 |
| 03:02 ET | 8444 | 3.15 |
| 03:03 ET | 9120 | 3.12 |
| 03:05 ET | 3555 | 3.13 |
| 03:07 ET | 200 | 3.125 |
| 03:09 ET | 877 | 3.125 |
| 03:12 ET | 923 | 3.125 |
| 03:14 ET | 5693 | 3.125 |
| 03:16 ET | 6187 | 3.13 |
| 03:18 ET | 572 | 3.13 |
| 03:20 ET | 800 | 3.125 |
| 03:21 ET | 5404 | 3.12 |
| 03:23 ET | 1500 | 3.125 |
| 03:25 ET | 1975 | 3.125 |
| 03:27 ET | 2847 | 3.125 |
| 03:30 ET | 2035 | 3.125 |
| 03:32 ET | 2331 | 3.125 |
| 03:34 ET | 1600 | 3.125 |
| 03:36 ET | 866 | 3.125 |
| 03:38 ET | 5307 | 3.105 |
| 03:39 ET | 300 | 3.105 |
| 03:41 ET | 500 | 3.105 |
| 03:43 ET | 3348 | 3.105 |
| 03:45 ET | 9028 | 3.095 |
| 03:48 ET | 11935 | 3.1091 |
| 03:50 ET | 2692 | 3.11 |
| 03:52 ET | 9932 | 3.1 |
| 03:54 ET | 7608 | 3.085 |
| 03:56 ET | 7300 | 3.08 |
| 03:57 ET | 27327 | 3.055 |
| 03:59 ET | 115195 | 3.06 |
Sep 16, 2024
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm, from 11:42AM ET on Monday Sep 16, 2024 by Dow Jones
11:42AM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amylyx Pharmaceuticals Inc | 220.6M | -1.2x | --- |
Organogenesis Holdings Inc | 379.2M | -22.6x | --- |
Amarin Corporation PLC | 257.6M | -7.6x | --- |
Ironwood Pharmaceuticals Inc | 658.1M | 93.0x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Coherus BioSciences Inc | 119.8M | -2.5x | --- |
Company Information
Amylyx Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is engaged in the discovery and development of treatments for neurodegenerative diseases. The Company is focused on the development and commercialization of its product candidate: AMX0035 for the treatment of Wolfram syndrome and for the treatment of progressive supranuclear palsy, and AMX0114, the Company’s antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis (ALS). AMX0035 is a dual-unfolded protein response (UPR)-Bax apoptosis inhibitor composed of PB and TURSO (also known as TUDCA). The Company’s Avexitide is an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist that has been evaluated in five clinical trials for post-bariatric hypoglycemia (PBH) and has also been studied in congenital hyperinsulinism (HI), two indications characterized by hyperinsulinemic hypoglycemia.
Contact Information
- Headquarters
- 43 THORNDIKE STREETCAMBRIDGE, MA, United States 02141
- Phone
- 617-682-0917
- Fax
- 302-636-5454
Executives
- Chair of the Board of Directors
- George Milne
- Co-Chief Executive Officer, Director
- Joshua Cohen
- Co-Chief Executive Officer, Director
- Justin Klee
- Chief Financial Officer
- James Frates
- Chief Legal Officer and General Counsel
- Gina Mazzariello
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $220.6M |
|---|---|
Revenue (TTM) | $298.8M |
Shares Outstanding | 68.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.45 |
Book Value | $6.40 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 0.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.50% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
